RE:RE:RE:RE:Vic knows what he's doing. Time is of the essence. Aphria has won awards for their CBD oil, as well as Broken Coast.
If you remember correctly, Health Canada's delay prevented Aphria from reaching their full revenue potential last quarter.
LEAF is valued 2/3 of APH because they do not come close to their international presence, supply deals, or current/future capacity.
I didn't realize that the goal here was to get bought out by Big Pharma/Tobacco/Alcohol before massive revenues kick in. Silly me.
Remember a few months ago when you were seriously considering selling all of your shares because you were upset with the direction management was going, and then you woke up to APH acquiring Broken Coast and forgot about your troubles real fast? Just chill out.
Sometimes, the market is asleep. Stay woke.
Buckshot26 wrote: why are you attributing 100% of the DD yield to APH?
LEAF wins award after award for the product they grow, APH can't claim a single award. At some point selling this stuff will trump over growing it right bud-light drinkers :)
LEAF and APH got their initial licenses in spring 2014 yet LEAF sold $11.35million last qtr while APH only did $8.5million.
LEAF is valued roughly at two thirds of APH.
LEAF gets bought out before APH in my opinio as it is clean of the US mess, cheaper and grows superior product.
kenster wrote: Aph vrs Leaf, Aph is expected to have 220,000 kgs for sale Jan 2019 at lowest cost per gram and a
25% discount price to Leaf Leaf still needs to close,retrofit and get a new license.l'll Stick with Vic